A new series of mycobacterial expression vectors for the development of live recombinant vaccines.
Recombinant BCG (bacillus Calmette-Guérin) is a promising candidate as a live vaccine delivery system. Thus far, however, only autoreplicative plasmids carrying the heterologous genes to be expressed in BCG, together with antibiotic-resistance genes, have been successfully used. This could potentially lead to the spreading of antibiotic resistance among other bacteria, and might therefore be unsafe for the environment. In this study, we present a series of three Escherichia coli-Mycobacteria shuttle vectors which enable expression and secretion of antigens without the use of antibiotic-resistance markers. All these plasmids confer mercury resistance to the host bacteria as the only selectable marker and contain a unique restriction site to allow for single-step in-frame cloning of open reading frames downstream from the Mycobacterium tuberculosis 85A antigen promoter and export signal. The system was used to express the free beta-subunit of human chorionic gonadotropin (hCG beta), a potential target of an immunotherapeutic vaccine.
Baulard
A
A
Laboratoire de Microbiologie Génétique et Moléculaire, INSERM CJF9109, Institut Pasteur de Lille, France.
Kremer
L
L
Supply
P
P
Vidaud
D
D
Bidart
J M
JM
Bellet
D
D
Locht
C
C
D000941:Antigens / Q000235:genetics* / Q000276:immunology; D015153:Blotting, Western; D006063:Chorionic Gonadotropin / Q000235:genetics* / Q000276:immunology; D003001:Cloning, Molecular; D015870:Gene Expression; D005822:Genetic Vectors; D006801:Humans; D015592:Immunoradiometric Assay; D009163:Mycobacterium bovis / Q000235:genetics*; D014614:Vaccines, Synthetic / Q000235:genetics* / Q000276:immunology
D000941:Antigens; D006063:Chorionic Gonadotropin; D014614:Vaccines, Synthetic